The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
NOS SGPS SA
ELI:NOS
|
PT |
|
Bukit Uluwatu Villa Tbk PT
IDX:BUVA
|
ID |
|
National Cinemedia Inc
NASDAQ:NCMI
|
US |
|
V
|
Verisk Analytics Inc
XMUN:VA7A
|
US |
|
UPM-Kymmene Oyj
F:RPL0
|
FI |
|
DBS Group Holdings Ltd
F:DEVL
|
SG |
|
B
|
BioneerCorp
KOSDAQ:064550
|
KR |
|
N
|
NOS SGPS SA
F:PMV
|
PT |
|
Centrotherm International AG
F:CTNK
|
DE |
|
W
|
WICE Logistics PCL
SET:WICE
|
TH |
|
Promotora y Operadora de Infraestructura SAB de CV
F:AKY
|
MX |
|
S
|
Shiseido Co Ltd
XMUN:SHD
|
JP |
|
P
|
Psybio Therapeutics Corp
OTC:PSYBF
|
CA |
|
Softronic AB
STO:SOF B
|
SE |
|
Shiseido Co Ltd
F:SHD
|
JP |
|
P
|
Principal Financial Group Inc
XMUN:PG4
|
US |
|
S
|
Scansource Inc
F:SC3
|
US |
|
F
|
Fujifilm Holdings Corp
DUS:FJI
|
JP |
|
Orior AG
SIX:ORON
|
CH |
|
WM Technology Inc
OTC:MAPS
|
US |
|
C
|
CITIC Securities Co Ltd
F:CI9
|
CN |
|
S
|
Sumitomo Pharma Co Ltd
XMUN:DPM
|
JP |
|
P
|
Premier Marketing PCL
SET:PM
|
TH |
NOS SGPS SA (NOS)’s 12-month stock price forecast through October 2027 has a consensus target of €5.304, implying 2% upside. The forecast is based on price targets from 13 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for NOS is 5.304 EUR with a low forecast of 3.939 EUR and a high forecast of 6.825 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 4 years is 2%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 1%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 4 years is 4%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 7%.
Over the last 13 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 4 years is -1%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more